Literature DB >> 32509760

Symptomatic Liver Metastasis Prompting Diagnosis of Uveal Melanoma.

Caroline C Awh1, Matthew W Wilson1.   

Abstract

We report the case of a 66-year-old male with symptomatic liver metastasis as the presenting manifestation of primary uveal melanoma. Upon initial presentation to an emergency department with 2 months of abdominal pain, back pain, and unintended weight loss, a computed tomography scan demonstrated diffuse liver and bone lesions, prompting referral to a medical oncologist. He was eventually examined by an ophthalmologist, who found a lesion suspicious for uveal melanoma. This was ultimately confirmed to be the primary site of his malignant metastatic melanoma, which caused his death within 2 months of presentation.
Copyright © 2019 by S. Karger AG, Basel.

Entities:  

Keywords:  Cytogenetics of uveal melanoma; Malignant melanoma; Uveal melanoma

Year:  2019        PMID: 32509760      PMCID: PMC7250353          DOI: 10.1159/000503035

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  13 in total

1.  Cytogenetic findings in six posterior uveal melanomas: involvement of chromosomes 3, 6, and 8.

Authors:  K Sisley; I G Rennie; D W Cottam; A M Potter; C W Potter; R C Rees
Journal:  Genes Chromosomes Cancer       Date:  1990-09       Impact factor: 5.006

2.  Development of metastatic disease after enrollment in the COMS trials for treatment of choroidal melanoma: Collaborative Ocular Melanoma Study Group Report No. 26.

Authors:  Marie Diener-West; Sandra M Reynolds; Donna J Agugliaro; Robert Caldwell; Kristi Cumming; John D Earle; Barbara S Hawkins; James A Hayman; Ishmael Jaiyesimi; Lee M Jampol; John M Kirkwood; Wui-Jin Koh; Dennis M Robertson; John M Shaw; Bradley R Straatsma; Jonni Thoma
Journal:  Arch Ophthalmol       Date:  2005-12

3.  Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.

Authors:  Y Aalto; L Eriksson; S Seregard; O Larsson; S Knuutila
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

4.  Prognostic implications of monosomy 3 in uveal melanoma.

Authors:  G Prescher; N Bornfeld; H Hirche; B Horsthemke; K H Jöckel; R Becher
Journal:  Lancet       Date:  1996-05-04       Impact factor: 79.321

5.  Whole body PET/CT for initial staging of choroidal melanoma.

Authors:  P T Finger; M Kurli; S Reddy; L B Tena; A C Pavlick
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

6.  Delayed systemic recurrence of uveal melanoma.

Authors:  Nathalie A Kolandjian; Caimiao Wei; Sapna P Patel; Jessica L Richard; Tina Dett; Nicholas E Papadopoulos; Agop Y Bedikian
Journal:  Am J Clin Oncol       Date:  2013-10       Impact factor: 2.339

Review 7.  Ocular melanoma: an overview of the current status.

Authors:  Predrag Jovanovic; Marija Mihajlovic; Jasmina Djordjevic-Jocic; Slobodan Vlajkovic; Sonja Cekic; Vladisav Stefanovic
Journal:  Int J Clin Exp Pathol       Date:  2013-06-15

8.  Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment.

Authors:  S Eskelin; S Pyrhönen; P Summanen; M Hahka-Kemppinen; T Kivelä
Journal:  Ophthalmology       Date:  2000-08       Impact factor: 12.079

9.  Very long-term prognosis of patients with malignant uveal melanoma.

Authors:  Emma Kujala; Teemu Mäkitie; Tero Kivelä
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

10.  Magnetic resonance imaging in the evaluation and differentiation of uveal melanoma.

Authors:  M F Mafee; G A Peyman; J H Peace; S B Cohen; M W Mitchell
Journal:  Ophthalmology       Date:  1987-04       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.